Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients

Clinical trial NCT06015061 · UNKNOWN

Trial details

NCT number: NCT06015061
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Pheochromocytoma, Metastatic Ultrasonography Paraganglioma, Malignant Pheochromocytoma Malignant

Start date: 2023-03-01
Primary completion: 2025-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.